In the Pharmaceutical Development Technology pillar, we develop highly efficient, environmentally sound processes for the production of active ingredients and the pharmaceutical products they can be made into. Our work includes the realisation of new catalytic hydrogenations, chemo-, regioselective and…
The main objectives of the Neuropharmacology Pillar are to conduct research on inflammatory and degenerative mechanisms in the nervous system, synthesis and development of new molecules, exploitation of new indications for existing drugs, development of screening tests in translational models,…
In the Molecular Oncology pillar, we use large genomic and transcriptomic databases to identify clinically applicable therapeutic options for patients with solid tumours who either currently have no suitable drug therapy or have developed resistance to available treatments. Our main…
The Biotechnology Pillar carries out diagnostic, therapeutic and technological developments. We are developing a laboratory-based (RT-real-time PCR) system and a point-of-care (RT-LAMP and CRISPR/Cas13a-based) test procedure for the DNA/RNA-based detection of pathogens. With the recombinant polymerases developed, we will have…